VolitionRX Limited (VNRX) Fundamentals

VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.
SHARE INFORMATION
Market Cap$ 130,289,566
Shares Outstanding63,555,886
Float45,402,522
Percent Float71.44%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 90,035
Latest Fiscal EPS$ -0.50
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions104
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months203,166
Institutional Holdings Percent15.5%
Institutional Sold Previous 3 Months2,647,491
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months10,000
Insider Holdings Percent8.3
Insider Sold Previous 3 Months-
Insider Shares Owned5,276,219
TRADING INFO
52 Week High$ 4.14
52 Week Low$ 1.95
52 Week High Change$ -37.69
21 Day Moving Average$ 2.2238
21 Day Extended Moving Average$ 2.1968
50 Day Moving Average$ 2.4288
50 Day Extended Moving Average$ 2.3834
200 Day Moving Average$ 2.9409
200 Day Extended Moving Average$ 2.831
10 Day Average Volume49,139
20 Day Average Volume49,648
30 Day Average Volume49,273
50 Day Average Volume63,230
Alpha-0.007425
Beta1.6555
Standard Deviation0.174922
R20.200869
7 Day Price Change$ -0.06
7 Day Percent Change-2.84%
21 Day Price Change$ -0.39
21 Day Percent Change-15.98%
30 Day Price Change$ -0.54
30 Day Percent Change-20.85%
Month to Date Price Change$ -0.54
Month to Date Percent Change-20.85%
Quarter to Date Price Change$ -0.96
Quarter to Date Percent Change-31.89%
180 Day Price Change$ -1.09
180 Day Percent Change-34.71%
200 Day Price Change$ -1.29
200 Day Percent Change-38.62%
Year to Date Price Change$ -1.09
Year to Date Percent Change-34.71%

VolitionRX Limited (VNRX) Key Ratios

PROFITABILITY
EBIT Margin-15,906.6%
EBITDA Margin-15,258.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 153,934
Revenue Per Share$ 0.0024
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book12.00
Total Debt To Equity0.40
Int Coverage-183.80
Current Ratio1.50
Leverage Ratio2.00
Quick Ratio0.00
Long Term Debt To Capital0.22
VALUATION MEASURES
PE Ratio-4.00
Enterprise Value$ 92,472,835
Price to Sales846.3989
Price to Free Cash-19.70
PE High Last 5 Years-7.10
Price To Book10.00
Price To Cash Flow0.00
PE Low Last 5 Years-6.30
Price to Tangible Book12.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.80
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-78.49
Return on Equity-133.84
Return on Capital-109.99

VolitionRX Limited (VNRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorSadler, Gibb & Associates, LLC
CEOCameron John. Reynolds
Emplyoees83
Last AuditUE
CIK0000093314
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address13215 Bee Cave Parkway
Suite 125, Galleria Oaks B
Austin, TX 78738
Websitehttps://www.volition.com
Facsimile-
Telephone+1 646 650-1351
Emailinvestorrelations@volition.com


Your Recent History
AMEX
VNRX
VolitionRX
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.